Approach to the Hypophosphatemic Patient

Por Imel, Erik A., Econs, Michael J.
Publicado em 2012

The Changing Face of Hypophosphatemic Disorders in the FGF-23 Era

Por Lee, Janet Y., Imel, Erik A.
Publicado em 2013

Hyperphosphatemic Familial Tumoral Calcinosis (FGF23, GALNT3, αKlotho)

Por Farrow, Emily G., Imel, Erik A., White, Kenneth E.
Publicado em 2011

Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients

Por Fisher, Marisa M, Cabrera, Susanne M, Imel, Erik A
Publicado no Endocrinol Diabetes Metab Case Rep (2015)

Iron and fibroblast growth factor 23 in X-linked hypophosphatemia

Por Imel, Erik A., Gray, Amie, Padgett, Leah, Econs, Michael J.
Publicado em 2013

Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations

Por Imel, Erik A., DiMeglio, Linda A., Hui, Siu L., Carpenter, Thomas O., Econs, Michael J.
Publicado em 2010

A CLINICIAN'S GUIDE TO X-LINKED HYPOPHOSPHATEMIA

Por Carpenter, Thomas O., Imel, Erik A., Holm, Ingrid A., Jan de Beur, Suzanne M., Insogna, Karl L.
Publicado em 2011

Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans

Por Imel, Erik A., Peacock, Munro, Gray, Amie K., Padgett, Leah R., Hui, Siu L., Econs, Michael J.
Publicado em 2011

The Case: Ectopic calcifications in a child

Por Keskar, Vaibhav S., Imel, Erik A., Kulkarni, Manjunath, Mane, Swati, Jamale, Tukaram E., Econs, Michael J., Hase, N.K.
Publicado no Kidney Int (2015)

Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women

Por Imel, Erik A., Liu, Ziyue, McQueen, Amie K., Acton, Dena, Acton, Anthony, Padgett, Leah R., Peacock, Munro, Econs, Michael J.
Publicado no Bone (2016)

Genome-wide association study of serum iron phenotypes in premenopausal women of European descent

Por Koller, Daniel L., Imel, Erik A., Lai, Dongbing, Padgett, Leah R., Acton, Dena, Gray, Amie, Peacock, Munro, Econs, Michael J., Foroud, Tatiana
Publicado no Blood Cells Mol Dis (2015)

Mutational Survey of the PHEX Gene in Patients with X-linked Hypophosphatemic Rickets

Por Ichikawa, Shoji, Traxler, Elizabeth A., Estwick, Selina A., Curry, Leah R., Johnson, Michelle L., Sorenson, Andrea H., Imel, Erik A., Econs, Michael J.
Publicado em 2008

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

Por Ichikawa, Shoji, Imel, Erik A., Kreiter, Mary L., Yu, Xijie, Mackenzie, Donald S., Sorenson, Andrea H., Goetz, Regina, Mohammadi, Moosa, White, Kenneth E., Econs, Michael J.
Publicado em 2007

Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: Report of a case and review of the literature

Por Woo, Victoria L., Landesberg, Regina, Imel, Erik A., Singer, Steven R., Folpe, Andrew L., Econs, Michael J., Kim, Taeyun, Harik, Lara R., Jacobs, Thomas P.
Publicado em 2009

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

Por Carpenter, Thomas O., Imel, Erik A., Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Wooddell, Margaret M., Kawakami, Tetsuyoshi, Ito, Takahiro, Zhang, Xiaoping, Humphrey, Jeffrey, Insogna, Karl L., Peacock, Munro
Publicado em 2014

FGF23 is elevated in multiple myeloma and increases heparanase expression by tumor cells

Por Suvannasankha, Attaya, Tompkins, Douglas R., Edwards, Daniel F., Petyaykina, Katarina V., Crean, Colin D., Fournier, Pierrick G., Parker, Jamie M., Sandusky, George E., Ichikawa, Shoji, Imel, Erik A., Chirgwin, John M.
Publicado no Oncotarget (2015)

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23

Por Imel, Erik A., Zhang, Xiaoping, Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey S., Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Peacock, Munro, Carpenter, Thomas O.
Publicado no J Clin Endocrinol Metab (2015)

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia

Por Ruppe, Mary D., Zhang, Xiaoping, Imel, Erik A., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey S., Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Peacock, Munro, Carpenter, Thomas O.
Publicado no Bone Rep (2016)

Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia...

Por Zhang, Xiaoping, Imel, Erik A., Ruppe, Mary D., Weber, Thomas J., Klausner, Mark A., Ito, Takahiro, Vergeire, Maria, Humphrey, Jeffrey, Glorieux, Francis H., Portale, Anthony A., Insogna, Karl, Carpenter, Thomas O., Peacock, Munro
Publicado no J Clin Pharmacol (2015)

Clinical Variability of Familial Tumoral Calcinosis Caused by Novel GALNT3 Mutations

Por Ichikawa, Shoji, Baujat, Geneviève, Seyahi, Aksel, Garoufali, Anastasia G., Imel, Erik A., Padgett, Leah R., Austin, Anthony M., Sorenson, Andrea H., Pejin, Zagorka, Topouchian, Vicken, Quartier, Pierre, Cormier-Daire, Valerie, Dechaux, Michele, Malandrinou, Fotini Ch., Singhellakis, Panagiotis N., Le Merrer, Martine, Econs, Michael J.
Publicado em 2010